Consensus on the use of neutrophil-stimulating hematopoietic growth factors in clinical practice: An international viewpoint

International Journal of Antimicrobial Agents

Volumn 8, Issue 4, 1997, Pages 263-275

  Rusthoven, James J ^a   De Vries, Elisabeth G E ^b   Dale, David C ^c   Piccart, Martine ^d   Glaspy, John ^e   Hamilton, Anne ^d  

^a JURAVINSKI CANCER CENTRE   (Canada)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^d JULES BORDET INSTITUTE   (Belgium)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Clinical practice; Myelosuppression; Neutrophil stimulating hematopoietic factors

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR;

BONE MARROW SUPPRESSION; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; DRUG USE; HUMAN; NEUTROPENIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

EID: 0030957228     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(97)00022-8     Document Type: Article

References (6)

1. Dale D, Bonilla MA, Davis MW, Nakanishi AM, Hammond WP, Kurtzber J. A randomized controlled phase III trial of recombinant human G-CSF for treatment of severe chronic neutropenia. Blood 1993;81:2496-502.
2. Ganser A, Ottmann OG, Erdmann H, Schulz G, Hoelzer D. The effect of recombinant human granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity in chronic severe neutropenia. Ann Intern Med 1989;111:887-92.
3. Vadhan-Raj S, Keating M, LeMaistre A, Hittelman WN, McCredie K. Trujillo JM, et al. Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes. New Engl J Med 1987;317:1545-52.
4. Crawford J, Ozer H, Stoller R, Johnson D, Lyman G, Tabbara I, Kris M, Grous J, Picozzi V, Rausch G, et al. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small cell lung cancer (r-metHuG-CSF). New Engl J Med 1991;325:164-70.
5. Nemunaitis J, Rabinowe SN, Singer JW, Bierman PJ, Vose JM, Freedman AS, Onetto N, Gillis S, Oette D, Gold M, et al. Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer. New Engl J Med 1991;324:1773-8.
6. Groopman JE. Granulocyte-macrophage colony-stimulating factor in human immunodeficiency virus disease. Semin Hemat 1990;27:8-14.